<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mercaldi GF</submitter><funding>Financiadora de Estudos e Projetos</funding><pagination>18500</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9628480</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>The nucleocapsid (N) protein plays critical roles in coronavirus genome transcription and packaging, representing a key target for the development of novel antivirals, and for which structural information on ligand binding is scarce. We used a novel fluorescence polarization assay to identify small molecules that disrupt the binding of the N protein to a target RNA derived from the SARS-CoV-2 genome packaging signal. Several phenolic compounds, including L-chicoric acid (CA), were identified as high-affinity N-protein ligands. The binding of CA to the N protein was confirmed by isothermal titration calorimetry, &lt;sup>1&lt;/sup>H-STD and &lt;sup>15&lt;/sup>N-HSQC NMR, and by the crystal structure of CA bound to the N protein C-terminal domain (CTD), further revealing a new modulatory site in the SARS</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor.</pubmed_title><pmcid>PMC9628480</pmcid><funding_grant_id>01.20.0003.00</funding_grant_id><pubmed_authors>Filho HVR</pubmed_authors><pubmed_authors>da Silva JC</pubmed_authors><pubmed_authors>Shimizu JF</pubmed_authors><pubmed_authors>Figueira ACM</pubmed_authors><pubmed_authors>Cordeiro AT</pubmed_authors><pubmed_authors>Proenca-Modena JL</pubmed_authors><pubmed_authors>Mercaldi GF</pubmed_authors><pubmed_authors>Zeri ACM</pubmed_authors><pubmed_authors>Rocco SA</pubmed_authors><pubmed_authors>Marques RE</pubmed_authors><pubmed_authors>Bezerra EHS</pubmed_authors><pubmed_authors>Tonoli CCC</pubmed_authors><pubmed_authors>Soprano AS</pubmed_authors><pubmed_authors>Lopes-de-Oliveira PS</pubmed_authors><pubmed_authors>Sforca ML</pubmed_authors><pubmed_authors>do Nascimento Faria J</pubmed_authors><pubmed_authors>Benedetti CE</pubmed_authors><pubmed_authors>da Cunha MG</pubmed_authors><pubmed_authors>Bruder M</pubmed_authors><pubmed_authors>Batista FAH</pubmed_authors><pubmed_authors>Nagai A</pubmed_authors><pubmed_authors>Bajgelman MC</pubmed_authors><pubmed_authors>Franchini KG</pubmed_authors><pubmed_authors>Nascimento AFZ</pubmed_authors><pubmed_authors>Trivella DBB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor.</name><description>The nucleocapsid (N) protein plays critical roles in coronavirus genome transcription and packaging, representing a key target for the development of novel antivirals, and for which structural information on ligand binding is scarce. We used a novel fluorescence polarization assay to identify small molecules that disrupt the binding of the N protein to a target RNA derived from the SARS-CoV-2 genome packaging signal. Several phenolic compounds, including L-chicoric acid (CA), were identified as high-affinity N-protein ligands. The binding of CA to the N protein was confirmed by isothermal titration calorimetry, &lt;sup>1&lt;/sup>H-STD and &lt;sup>15&lt;/sup>N-HSQC NMR, and by the crystal structure of CA bound to the N protein C-terminal domain (CTD), further revealing a new modulatory site in the SARS</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-27T23:47:04.744Z</modification><creation>2024-12-04T12:33:06.027Z</creation></dates><accession>S-EPMC9628480</accession><cross_references><pubmed>36323732</pubmed><doi>10.1038/s41598-022-22576-4</doi></cross_references></HashMap>